APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Cell Immortalization

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Cell Immortalization Market Analysis and Forecast 2026-2032

Report ID 17408783024 June 2026243 pages

Choose your research edition.

Industry ResearchCell Immortalization Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell Immortalization Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Cell Immortalization Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell Immortalization Market Outlook and Growth Opportunities 2026205 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell Immortalization Market Analysis and Forecast 2026-2032243 pages · $4,950 USD

Market perspective

The global Cell Immortalization market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Cell Immortalization is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Cell Immortalization is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Cell Immortalization is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Cell Immortalization is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Cell Immortalization include Lonza, Thermo Fisher Scientific, JSR, Sartorius, Merck, AcceGen, Creative Biolabs, InSCREENex GmbH and BioIVT, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Cell Immortalization, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cell Immortalization, also provides the revenue of main regions and countries. Of the upcoming market potential for Cell Immortalization, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cell Immortalization revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cell Immortalization market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cell Immortalization revenue, projected growth trends, production technology, application and end-user industry.

Cell Immortalization Segment by Company

Lonza

Thermo Fisher Scientific

JSR

Sartorius

Merck

AcceGen

Creative Biolabs

InSCREENex GmbH

BioIVT

Krishgen Biosystems

Applied Biological Materials

REPROCELL Inc

FUJIFILM Wako Pure Chemical Corporation

Abace Biotechnology

CELLCOOK

Procell

Takara Bio

Corning

Evercyte

Cell Immortalization Segment by Type

Stem Cell Therapy

Cell Transplantation

Drug Transport

Others

Cell Immortalization Segment by Application

Pharmaceutical and Biopharmaceutical Company

Research Laboratory

Hospital

Other

Cell Immortalization Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Immortalization market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell Immortalization and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Immortalization.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cell Immortalization in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cell Immortalization company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Immortalization revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell Immortalization Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Stem Cell Therapy Major Player Table 3. Cell Transplantation Major Player Table 4. Drug Transport Major Player Table 5. Others Major Player Table 6. Global Cell Immortalization Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceutical and Biopharmaceutical Company Major Player Table 8. Research Laboratory Major Player Table 9. Hospital Major Player Table 10. Other Major Player Table 11. Cell Immortalization Industry Trends Table 12. Cell Immortalization Industry Drivers Table 13. Cell Immortalization Industry Opportunities and Challenges Table 14. Cell Immortalization Industry Restraints Table 15. Global Cell Immortalization Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Cell Immortalization Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Cell Immortalization Market Share by Region (2021-2026) Table 18. Global Cell Immortalization Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Cell Immortalization Market Share by Region (2027-2032) Table 20. Global Cell Immortalization Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Cell Immortalization Revenue Market Share by Players (2021-2026) Table 22. Global Cell Immortalization Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Cell Immortalization Key Players Headquarters & Area Served Table 24. Global Cell Immortalization Players, Product Type & Application Table 25. Global Cell Immortalization Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Cell Immortalization by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Cell Immortalization Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Cell Immortalization Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Cell Immortalization Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Cell Immortalization Revenue Market Share by Type (2021-2026) Table 32. Global Cell Immortalization Revenue Market Share by Type (2027-2032) Table 33. Global Cell Immortalization Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Cell Immortalization Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Cell Immortalization Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Cell Immortalization Revenue Market Share by Application (2021-2026) Table 37. Global Cell Immortalization Revenue Market Share by Application (2027-2032) Table 38. Lonza Company Information Table 39. Lonza Business Overview Table 40. Lonza Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Lonza Cell Immortalization Product Portfolio Table 42. Lonza Recent Development Table 43. Thermo Fisher Scientific Company Information Table 44. Thermo Fisher Scientific Business Overview Table 45. Thermo Fisher Scientific Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Thermo Fisher Scientific Cell Immortalization Product Portfolio Table 47. Thermo Fisher Scientific Recent Development Table 48. JSR Company Information Table 49. JSR Business Overview Table 50. JSR Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. JSR Cell Immortalization Product Portfolio Table 52. JSR Recent Development Table 53. Sartorius Company Information Table 54. Sartorius Business Overview Table 55. Sartorius Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Sartorius Cell Immortalization Product Portfolio Table 57. Sartorius Recent Development Table 58. Merck Company Information Table 59. Merck Business Overview Table 60. Merck Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Merck Cell Immortalization Product Portfolio Table 62. Merck Recent Development Table 63. AcceGen Company Information Table 64. AcceGen Business Overview Table 65. AcceGen Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. AcceGen Cell Immortalization Product Portfolio Table 67. AcceGen Recent Development Table 68. Creative Biolabs Company Information Table 69. Creative Biolabs Business Overview Table 70. Creative Biolabs Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Creative Biolabs Cell Immortalization Product Portfolio Table 72. Creative Biolabs Recent Development Table 73. InSCREENex GmbH Company Information Table 74. InSCREENex GmbH Business Overview Table 75. InSCREENex GmbH Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. InSCREENex GmbH Cell Immortalization Product Portfolio Table 77. InSCREENex GmbH Recent Development Table 78. BioIVT Company Information Table 79. BioIVT Business Overview Table 80. BioIVT Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. BioIVT Cell Immortalization Product Portfolio Table 82. BioIVT Recent Development Table 83. Krishgen Biosystems Company Information Table 84. Krishgen Biosystems Business Overview Table 85. Krishgen Biosystems Cell Immortalization Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Krishgen Biosystems Cell Immortalization Product Portfolio Table 87. Krishgen Biosystems Recent Development Table 88. Applied Biological Materials Company Information Table 89. Applied Biological Materials Business Overview Table 90. Applied Biological Materials Cell Immortalization Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Applied Biological Materials Cell Immortalization Product Portfolio Table 92. Applied Biological Materials Recent Development Table 93. REPROCELL Inc Company Information Table 94. REPROCELL Inc Business Overview Table 95. REPROCELL Inc Cell Immortalization Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. REPROCELL Inc Cell Immortalization Product Portfolio Table 97. REPROCELL Inc Recent Development Table 98. FUJIFILM Wako Pure Chemical Corporation Company Information Table 99. FUJIFILM Wako Pure Chemical Corporation Business Overview Table 100. FUJIFILM Wako Pure Chemical Corporation Cell Immortalization Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. FUJIFILM Wako Pure Chemical Corporation Cell Immortalization Product Portfolio Table 102. FUJIFILM Wako Pure Chemical Corporation Recent Development Table 103. Abace Biotechnology Company Information Table 104. Abace Biotechnology Business Overview Table 105. Abace Biotechnology Cell Immortalization Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Abace Biotechnology Cell Immortalization Product Portfolio Table 107. Abace Biotechnology Recent Development Table 108. CELLCOOK Company Information Table 109. CELLCOOK Business Overview Table 110. CELLCOOK Cell Immortalization Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. CELLCOOK Cell Immortalization Product Portfolio Table 112. CELLCOOK Recent Development Table 113. Procell Company Information Table 114. Procell Business Overview Table 115. Procell Cell Immortalization Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Procell Cell Immortalization Product Portfolio Table 117. Procell Recent Development Table 118. Takara Bio Company Information Table 119. Takara Bio Business Overview Table 120. Takara Bio Cell Immortalization Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Takara Bio Cell Immortalization Product Portfolio Table 122. Takara Bio Recent Development Table 123. Corning Company Information Table 124. Corning Business Overview Table 125. Corning Cell Immortalization Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Corning Cell Immortalization Product Portfolio Table 127. Corning Recent Development Table 128. Evercyte Company Information Table 129. Evercyte Business Overview Table 130. Evercyte Cell Immortalization Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. Evercyte Cell Immortalization Product Portfolio Table 132. Evercyte Recent Development Table 133. North America Cell Immortalization Revenue by Type (2021-2026) & (US$ Million) Table 134. North America Cell Immortalization Revenue by Type (2027-2032) & (US$ Million) Table 135. North America Cell Immortalization Revenue by Application (2021-2026) & (US$ Million) Table 136. North America Cell Immortalization Revenue by Application (2027-2032) & (US$ Million) Table 137. North America Cell Immortalization Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. North America Cell Immortalization Revenue by Country (2021-2026) & (US$ Million) Table 139. North America Cell Immortalization Revenue by Country (US$ Million) & (2027-2032) Table 140. Europe Cell Immortalization Revenue by Type (2021-2026) & (US$ Million) Table 141. Europe Cell Immortalization Revenue by Type (2027-2032) & (US$ Million) Table 142. Europe Cell Immortalization Revenue by Application (2021-2026) & (US$ Million) Table 143. Europe Cell Immortalization Revenue by Application (2027-2032) & (US$ Million) Table 144. Europe Cell Immortalization Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Europe Cell Immortalization Revenue by Country (2021-2026) & (US$ Million) Table 146. Europe Cell Immortalization Revenue by Country (US$ Million) & (2027-2032) Table 147. China Cell Immortalization Revenue by Type (2021-2026) & (US$ Million) Table 148. China Cell Immortalization Revenue by Type (2027-2032) & (US$ Million) Table 149. China Cell Immortalization Revenue by Application (2021-2026) & (US$ Million) Table 150. China Cell Immortalization Revenue by Application (2027-2032) & (US$ Million) Table 151. Asia Cell Immortalization Revenue by Type (2021-2026) & (US$ Million) Table 152. Asia Cell Immortalization Revenue by Type (2027-2032) & (US$ Million) Table 153. Asia Cell Immortalization Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Cell Immortalization Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Cell Immortalization Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 156. Asia Cell Immortalization Revenue by Region (US$ Million) & (2021-2026) Table 157. Asia Cell Immortalization Revenue by Region (US$ Million) & (2027-2032) Table 158. SAMEA Cell Immortalization Revenue by Type (2021-2026) & (US$ Million) Table 159. SAMEA Cell Immortalization Revenue by Type (2027-2032) & (US$ Million) Table 160. SAMEA Cell Immortalization Revenue by Application (2021-2026) & (US$ Million) Table 161. SAMEA Cell Immortalization Revenue by Application (2027-2032) & (US$ Million) Table 162. SAMEA Cell Immortalization Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. SAMEA Cell Immortalization Revenue by Country (2021-2026) & (US$ Million) Table 164. SAMEA Cell Immortalization Revenue by Country (US$ Million) & (2027-2032) Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Cell Immortalization Image Figure 2. Global Cell Immortalization Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell Immortalization Market Size Share 2021 VS 2025 VS 2032 Figure 4. Stem Cell Therapy Image Figure 5. Cell Transplantation Image Figure 6. Drug Transport Image Figure 7. Others Image Figure 8. Global Cell Immortalization Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Cell Immortalization Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceutical and Biopharmaceutical Company Image Figure 11. Research Laboratory Image Figure 12. Hospital Image Figure 13. Other Image Figure 14. Global Cell Immortalization Market Size (US$ Million) & (2021-2032) Figure 15. Global Cell Immortalization Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Cell Immortalization Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Cell Immortalization Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Cell Immortalization Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Cell Immortalization Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Cell Immortalization Revenue Market Share by Type (2021-2032) Figure 22. Global Cell Immortalization Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Cell Immortalization Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Cell Immortalization Revenue Market Share by Application (2021-2032) Figure 25. North America Cell Immortalization Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Cell Immortalization Revenue Share by Type (2021-2032) Figure 27. North America Cell Immortalization Revenue Share by Application (2021-2032) Figure 28. North America Cell Immortalization Revenue Share by Country (2021-2032) Figure 29. United States Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Cell Immortalization Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Cell Immortalization Revenue Share by Type (2021-2032) Figure 34. Europe Cell Immortalization Revenue Share by Application (2021-2032) Figure 35. Europe Cell Immortalization Revenue Share by Country (2021-2032) Figure 36. Germany Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Cell Immortalization Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Cell Immortalization Revenue Share by Type (2021-2032) Figure 46. China Cell Immortalization Revenue Share by Application (2021-2032) Figure 47. Asia Cell Immortalization Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Cell Immortalization Revenue Share by Type (2021-2032) Figure 49. Asia Cell Immortalization Revenue Share by Application (2021-2032) Figure 50. Asia Cell Immortalization Revenue Share by Region (2021-2032) Figure 51. Japan Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Cell Immortalization Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Cell Immortalization Revenue Share by Type (2021-2032) Figure 59. SAMEA Cell Immortalization Revenue Share by Application (2021-2032) Figure 60. SAMEA Cell Immortalization Revenue Share by Country (2021-2032) Figure 61. Brazil Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Cell Immortalization Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Stem Cell Therapy
  • Cell Transplantation
  • Drug Transport
  • Others
Applications
  • Pharmaceutical and Biopharmaceutical Company
  • Research Laboratory
  • Hospital
  • Other
Companies covered
  • Lonza
  • Thermo Fisher Scientific
  • JSR
  • Sartorius
  • Merck
  • AcceGen
  • Creative Biolabs
  • InSCREENex GmbH
  • BioIVT
  • Krishgen Biosystems
  • Applied Biological Materials
  • REPROCELL Inc
  • FUJIFILM Wako Pure Chemical Corporation
  • Abace Biotechnology
  • CELLCOOK
  • Procell
  • Takara Bio
  • Corning
  • Evercyte

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cell Immortalization Market by Type
  3. 1.2.1 Global Cell Immortalization Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Stem Cell Therapy
  5. 1.2.3 Cell Transplantation
  6. 1.2.4 Drug Transport
  7. 1.2.5 Others
  8. 1.3 Cell Immortalization Market by Application
  9. 1.3.1 Global Cell Immortalization Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical and Biopharmaceutical Company
  11. 1.3.3 Research Laboratory
  12. 1.3.4 Hospital
  13. 1.3.5 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Cell Immortalization Market Dynamics
  1. 2.1 Cell Immortalization Industry Trends
  2. 2.2 Cell Immortalization Industry Drivers
  3. 2.3 Cell Immortalization Industry Opportunities and Challenges
  4. 2.4 Cell Immortalization Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cell Immortalization Market Perspective (2021-2032)
  2. 3.2 Global Cell Immortalization Growth Trends by Region
  3. 3.2.1 Global Cell Immortalization Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cell Immortalization Market Size by Region (2021-2026)
  5. 3.2.3 Global Cell Immortalization Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cell Immortalization Revenue by Players
  2. 4.1.1 Global Cell Immortalization Revenue by Players (2021-2026)
  3. 4.1.2 Global Cell Immortalization Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cell Immortalization Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cell Immortalization Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cell Immortalization Key Players Headquarters & Area Served
  7. 4.4 Global Cell Immortalization Players, Product Type & Application
  8. 4.5 Global Cell Immortalization Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cell Immortalization Market CR5 and HHI
  11. 4.6.3 2025 Cell Immortalization Tier 1, Tier 2, and Tier 3
5 Cell Immortalization Market Size by Type
  1. 5.1 Global Cell Immortalization Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell Immortalization Revenue by Type (2021-2032)
  3. 5.3 Global Cell Immortalization Revenue Market Share by Type (2021-2032)
6 Cell Immortalization Market Size by Application
  1. 6.1 Global Cell Immortalization Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cell Immortalization Revenue by Application (2021-2032)
  3. 6.3 Global Cell Immortalization Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Lonza
  2. 7.1.1 Lonza Company Information
  3. 7.1.2 Lonza Business Overview
  4. 7.1.3 Lonza Cell Immortalization Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Lonza Cell Immortalization Product Portfolio
  6. 7.1.5 Lonza Recent Developments
  7. 7.2 Thermo Fisher Scientific
  8. 7.2.1 Thermo Fisher Scientific Company Information
  9. 7.2.2 Thermo Fisher Scientific Business Overview
  10. 7.2.3 Thermo Fisher Scientific Cell Immortalization Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Thermo Fisher Scientific Cell Immortalization Product Portfolio
  12. 7.2.5 Thermo Fisher Scientific Recent Developments
  13. 7.3 JSR
  14. 7.3.1 JSR Company Information
  15. 7.3.2 JSR Business Overview
  16. 7.3.3 JSR Cell Immortalization Revenue and Gross Margin (2021-2026)
  17. 7.3.4 JSR Cell Immortalization Product Portfolio
  18. 7.3.5 JSR Recent Developments
  19. 7.4 Sartorius
  20. 7.4.1 Sartorius Company Information
  21. 7.4.2 Sartorius Business Overview
  22. 7.4.3 Sartorius Cell Immortalization Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Sartorius Cell Immortalization Product Portfolio
  24. 7.4.5 Sartorius Recent Developments
  25. 7.5 Merck
  26. 7.5.1 Merck Company Information
  27. 7.5.2 Merck Business Overview
  28. 7.5.3 Merck Cell Immortalization Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Merck Cell Immortalization Product Portfolio
  30. 7.5.5 Merck Recent Developments
  31. 7.6 AcceGen
  32. 7.6.1 AcceGen Company Information
  33. 7.6.2 AcceGen Business Overview
  34. 7.6.3 AcceGen Cell Immortalization Revenue and Gross Margin (2021-2026)
  35. 7.6.4 AcceGen Cell Immortalization Product Portfolio
  36. 7.6.5 AcceGen Recent Developments
  37. 7.7 Creative Biolabs
  38. 7.7.1 Creative Biolabs Company Information
  39. 7.7.2 Creative Biolabs Business Overview
  40. 7.7.3 Creative Biolabs Cell Immortalization Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Creative Biolabs Cell Immortalization Product Portfolio
  42. 7.7.5 Creative Biolabs Recent Developments
  43. 7.8 InSCREENex GmbH
  44. 7.8.1 InSCREENex GmbH Company Information
  45. 7.8.2 InSCREENex GmbH Business Overview
  46. 7.8.3 InSCREENex GmbH Cell Immortalization Revenue and Gross Margin (2021-2026)
  47. 7.8.4 InSCREENex GmbH Cell Immortalization Product Portfolio
  48. 7.8.5 InSCREENex GmbH Recent Developments
  49. 7.9 BioIVT
  50. 7.9.1 BioIVT Company Information
  51. 7.9.2 BioIVT Business Overview
  52. 7.9.3 BioIVT Cell Immortalization Revenue and Gross Margin (2021-2026)
  53. 7.9.4 BioIVT Cell Immortalization Product Portfolio
  54. 7.9.5 BioIVT Recent Developments
  55. 7.10 Krishgen Biosystems
  56. 7.10.1 Krishgen Biosystems Company Information
  57. 7.10.2 Krishgen Biosystems Business Overview
  58. 7.10.3 Krishgen Biosystems Cell Immortalization Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Krishgen Biosystems Cell Immortalization Product Portfolio
  60. 7.10.5 Krishgen Biosystems Recent Developments
  61. 7.11 Applied Biological Materials
  62. 7.11.1 Applied Biological Materials Company Information
  63. 7.11.2 Applied Biological Materials Business Overview
  64. 7.11.3 Applied Biological Materials Cell Immortalization Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Applied Biological Materials Cell Immortalization Product Portfolio
  66. 7.11.5 Applied Biological Materials Recent Developments
  67. 7.12 REPROCELL Inc
  68. 7.12.1 REPROCELL Inc Company Information
  69. 7.12.2 REPROCELL Inc Business Overview
  70. 7.12.3 REPROCELL Inc Cell Immortalization Revenue and Gross Margin (2021-2026)
  71. 7.12.4 REPROCELL Inc Cell Immortalization Product Portfolio
  72. 7.12.5 REPROCELL Inc Recent Developments
  73. 7.13 FUJIFILM Wako Pure Chemical Corporation
  74. 7.13.1 FUJIFILM Wako Pure Chemical Corporation Company Information
  75. 7.13.2 FUJIFILM Wako Pure Chemical Corporation Business Overview
  76. 7.13.3 FUJIFILM Wako Pure Chemical Corporation Cell Immortalization Revenue and Gross Margin (2021-2026)
  77. 7.13.4 FUJIFILM Wako Pure Chemical Corporation Cell Immortalization Product Portfolio
  78. 7.13.5 FUJIFILM Wako Pure Chemical Corporation Recent Developments
  79. 7.14 Abace Biotechnology
  80. 7.14.1 Abace Biotechnology Company Information
  81. 7.14.2 Abace Biotechnology Business Overview
  82. 7.14.3 Abace Biotechnology Cell Immortalization Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Abace Biotechnology Cell Immortalization Product Portfolio
  84. 7.14.5 Abace Biotechnology Recent Developments
  85. 7.15 CELLCOOK
  86. 7.15.1 CELLCOOK Company Information
  87. 7.15.2 CELLCOOK Business Overview
  88. 7.15.3 CELLCOOK Cell Immortalization Revenue and Gross Margin (2021-2026)
  89. 7.15.4 CELLCOOK Cell Immortalization Product Portfolio
  90. 7.15.5 CELLCOOK Recent Developments
  91. 7.16 Procell
  92. 7.16.1 Procell Company Information
  93. 7.16.2 Procell Business Overview
  94. 7.16.3 Procell Cell Immortalization Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Procell Cell Immortalization Product Portfolio
  96. 7.16.5 Procell Recent Developments
  97. 7.17 Takara Bio
  98. 7.17.1 Takara Bio Company Information
  99. 7.17.2 Takara Bio Business Overview
  100. 7.17.3 Takara Bio Cell Immortalization Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Takara Bio Cell Immortalization Product Portfolio
  102. 7.17.5 Takara Bio Recent Developments
  103. 7.18 Corning
  104. 7.18.1 Corning Company Information
  105. 7.18.2 Corning Business Overview
  106. 7.18.3 Corning Cell Immortalization Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Corning Cell Immortalization Product Portfolio
  108. 7.18.5 Corning Recent Developments
  109. 7.19 Evercyte
  110. 7.19.1 Evercyte Company Information
  111. 7.19.2 Evercyte Business Overview
  112. 7.19.3 Evercyte Cell Immortalization Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Evercyte Cell Immortalization Product Portfolio
  114. 7.19.5 Evercyte Recent Developments
8 North America
  1. 8.1 North America Cell Immortalization Revenue (2021-2032)
  2. 8.2 North America Cell Immortalization Revenue by Type (2021-2032)
  3. 8.2.1 North America Cell Immortalization Revenue by Type (2021-2026)
  4. 8.2.2 North America Cell Immortalization Revenue by Type (2027-2032)
  5. 8.3 North America Cell Immortalization Revenue Share by Type (2021-2032)
  6. 8.4 North America Cell Immortalization Revenue by Application (2021-2032)
  7. 8.4.1 North America Cell Immortalization Revenue by Application (2021-2026)
  8. 8.4.2 North America Cell Immortalization Revenue by Application (2027-2032)
  9. 8.5 North America Cell Immortalization Revenue Share by Application (2021-2032)
  10. 8.6 North America Cell Immortalization Revenue by Country
  11. 8.6.1 North America Cell Immortalization Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cell Immortalization Revenue by Country (2021-2026)
  13. 8.6.3 North America Cell Immortalization Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cell Immortalization Revenue (2021-2032)
  2. 9.2 Europe Cell Immortalization Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cell Immortalization Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cell Immortalization Revenue by Type (2027-2032)
  5. 9.3 Europe Cell Immortalization Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cell Immortalization Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cell Immortalization Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cell Immortalization Revenue by Application (2027-2032)
  9. 9.5 Europe Cell Immortalization Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cell Immortalization Revenue by Country
  11. 9.6.1 Europe Cell Immortalization Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cell Immortalization Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cell Immortalization Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cell Immortalization Revenue (2021-2032)
  2. 10.2 China Cell Immortalization Revenue by Type (2021-2032)
  3. 10.2.1 China Cell Immortalization Revenue by Type (2021-2026)
  4. 10.2.2 China Cell Immortalization Revenue by Type (2027-2032)
  5. 10.3 China Cell Immortalization Revenue Share by Type (2021-2032)
  6. 10.4 China Cell Immortalization Revenue by Application (2021-2032)
  7. 10.4.1 China Cell Immortalization Revenue by Application (2021-2026)
  8. 10.4.2 China Cell Immortalization Revenue by Application (2027-2032)
  9. 10.5 China Cell Immortalization Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cell Immortalization Revenue (2021-2032)
  2. 11.2 Asia Cell Immortalization Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cell Immortalization Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cell Immortalization Revenue by Type (2027-2032)
  5. 11.3 Asia Cell Immortalization Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cell Immortalization Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cell Immortalization Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cell Immortalization Revenue by Application (2027-2032)
  9. 11.5 Asia Cell Immortalization Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cell Immortalization Revenue by Country
  11. 11.6.1 Asia Cell Immortalization Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cell Immortalization Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cell Immortalization Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cell Immortalization Revenue (2021-2032)
  2. 12.2 SAMEA Cell Immortalization Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cell Immortalization Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cell Immortalization Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cell Immortalization Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cell Immortalization Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cell Immortalization Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cell Immortalization Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cell Immortalization Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cell Immortalization Revenue by Country
  11. 12.6.1 SAMEA Cell Immortalization Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cell Immortalization Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cell Immortalization Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst